Table 4.
Correlations between number of active lesions, their SUVmax, and biochemical and clinical disease activity parameters in patients with CNO.
| ESR | CRP | P1NP | CTx | ALP | VAS (pain) | |
|---|---|---|---|---|---|---|
| No. of active bone lesions (range 1–13) | 0.285* | 0.200 | −0.002 | 0.306* | 0.307* | 0.318* |
| No. of active soft tissue/joint lesions (range 0–11) | 0.160 | −0.061 | −0.184 | 0.045 | 0.001 | 0.167 |
| Mean SUVmax bone lesions | −0.083 | −0.196 | 0.163 | 0.231 | 0.105 | −0.127 |
| Mean SUVmax soft tissue/joint lesions | 0.546** | 0.214 | 0.088 | −0.145 | 0.255 | −0.127 |
Abbreviations: ALP, alkaline phosphatase; CNO, chronic nonbacterial osteitis; CRP, C-reactive protein; CTx, C-terminal telopeptide of type 1 collagen; ESR, erythrocyte sedimentation rate; P1NP, procollagen 1N-terminal propeptide; SUVmax, maximum standardized uptake value; VAS, visual analog scale.
*p < .05, **p < .01.